Impact of COVID-19 related alterations in circulating respiratory viruses on children and adult patients with recurrent wheeze and asthma

A. Peck (Munich, Germany), N. Maison (Munich, Germany), A. Hose (Munich, Germany), J. Omony (Munich, Germany), B. Schaub (Munich, Germany), R. Grychtol (Hannover, Germany), A. Dittrich (Hannover, Germany), C. Nitsche (Luebeck, Germany), S. Foth (Marburg, Germany), M. Weckmann (Luebeck, Germany), M. Abdo (Grosshansdorf, Germany), T. Bahmer (Grosshansdorf, Germany), K. Rabe (Grosshansdorf, Germany), H. Renz (Marburg, Germany), G. Hansen (Hannover, Germany), M. Kopp (Bern, Switzerland), E. Von Mutius (Munich, Germany)

Source: International Congress 2022 – Influence of infections, risk factors and biomarkers in paediatric asthma
Session: Influence of infections, risk factors and biomarkers in paediatric asthma
Session type: Thematic Poster
Number: 3948

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Peck (Munich, Germany), N. Maison (Munich, Germany), A. Hose (Munich, Germany), J. Omony (Munich, Germany), B. Schaub (Munich, Germany), R. Grychtol (Hannover, Germany), A. Dittrich (Hannover, Germany), C. Nitsche (Luebeck, Germany), S. Foth (Marburg, Germany), M. Weckmann (Luebeck, Germany), M. Abdo (Grosshansdorf, Germany), T. Bahmer (Grosshansdorf, Germany), K. Rabe (Grosshansdorf, Germany), H. Renz (Marburg, Germany), G. Hansen (Hannover, Germany), M. Kopp (Bern, Switzerland), E. Von Mutius (Munich, Germany). Impact of COVID-19 related alterations in circulating respiratory viruses on children and adult patients with recurrent wheeze and asthma. 3948

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.